Literature DB >> 20831875

Synergistic effects in the designs of neuraminidase ligands: analysis from docking and molecular dynamics studies.

Zhiwei Yang1, Yingkun Nie, Gang Yang, Yuangang Zu, Yujie Fu, Lijun Zhou.   

Abstract

Docking and molecular dynamics were used to study the nine ligands (see Scheme 1) at the neuraminidase (NA) active sites. Their binding modes are structurally and energetically different, with details given in the text. Compared with 1A (oseltamivir carboxylate), the changes of core template or/and functional groups in the other ligands cause the reductions of interaction energies and numbers of H-bonds with the NA proteins. Nonetheless, all these ligands occupy the proximity space at the NA active sites and share some commonness in their binding modes. The fragment approach was then used to analyze and understand the binding specificities of the nine ligands. The contributions of each core template and functional group were evaluated. It was found that the core templates rather than functional groups play a larger role during the binding processes; in addition, the binding qualities are determined by the synergistic effects of the core templates and functional groups. Among the nine ligands, 1A (oseltamivir carboxylate) has the largest synergistic energy and its functional groups fit perfectly with the NA active site, consistent with the largest interaction energy, numerous H-bonds with the NA active-site residues as well as experimentally lowest IC(50) value. Owing to the poorer metabolizability than oseltamivir, large contribution of the benzene core template and fine synergistic effects of the functional groups, the 4-(N-acetylamino)-5-guanidino-3-(3-pentyloxy)benzoic acid should be an ideal lead compound for optimizing NA drugs.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831875     DOI: 10.1016/j.jtbi.2010.08.029

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  9 in total

1.  Linobiflavonoid inhibits human lung adenocarcinoma A549 cells: effect on tubulin protein.

Authors:  Dongbo Zhao; Guang Yang; Qingyang Meng; Junxing Liu; Shuang Yang
Journal:  Mol Biol Rep       Date:  2013-09-23       Impact factor: 2.316

2.  Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study.

Authors:  Zhiwei Yang; Gang Yang; Lijun Zhou
Journal:  J Comput Aided Mol Des       Date:  2013-11-12       Impact factor: 3.686

3.  Inhibitory action of chamaejasmin A against human HEP-2 epithelial cells: effect on tubulin protein.

Authors:  Yan Zhao; Fenglian Wu; Yu Wang; Shengwu Chen; Guojun Han; Ming Liu; Dejun Jin
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

4.  Computer-based de novo designs of tripeptides as novel neuraminidase inhibitors.

Authors:  Zhiwei Yang; Gang Yang; Yuangang Zu; Yujie Fu; Lijun Zhou
Journal:  Int J Mol Sci       Date:  2010-12-01       Impact factor: 5.923

5.  Genome-wide identification and in silico analysis of poplar peptide deformylases.

Authors:  Chang-Cai Liu; Bao-Guang Liu; Zhi-Wei Yang; Chun-Ming Li; Bai-Chen Wang; Chuan-Ping Yang
Journal:  Int J Mol Sci       Date:  2012-04-23       Impact factor: 6.208

Review 6.  Molecular dynamics, monte carlo simulations, and langevin dynamics: a computational review.

Authors:  Eric Paquet; Herna L Viktor
Journal:  Biomed Res Int       Date:  2015-02-16       Impact factor: 3.411

7.  Anticancer activity of chamaejasmine: effect on tubulin protein.

Authors:  Wenlong Fang; Songtao Liu; Yingkun Nie
Journal:  Molecules       Date:  2011-07-25       Impact factor: 4.411

8.  Inhibitory effect and possible mechanism of action of patchouli alcohol against influenza A (H2N2) virus.

Authors:  Huaxing Wu; Beili Li; Xue Wang; Mingyuan Jin; Guonian Wang
Journal:  Molecules       Date:  2011-08-03       Impact factor: 4.411

9.  Using parallelized incremental meta-docking can solve the conformational sampling issue when docking large ligands to proteins.

Authors:  Didier Devaurs; Dinler A Antunes; Sarah Hall-Swan; Nicole Mitchell; Mark Moll; Gregory Lizée; Lydia E Kavraki
Journal:  BMC Mol Cell Biol       Date:  2019-09-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.